Health Law Observer
Timely insights and legal commentary on various health care issues and developments surrounding regulations, employment, transactions and a range of key industry matters. This blog is maintained by the Health Care Department of Stevens & Lee.
Materiality scrapes in health care transactions are extraordinarily meaningful to a seller’s potential post-closing financial exposure.
Management fee arrangements with MSOs can take several forms depending on a specific state’s corporate practice of medicine compliance.
Unlike many privacy laws that apply only to businesses processing large volumes of personal data, this new law applies broadly and can impact organizations regardless of size.
Heppner underscores that using public AI tools with health care organization information may be considered as disclosure to a third party.
This legislation is intended to expand practice opportunities for PAs in Delaware as well as increase access to health care for Delaware residents.
New Jersey recently licensed its first Mobile Integrated Health program, allowing licensed paramedics and EMTs to deliver non-emergency clinical services to patients in their homes.
A recent uptick in enforcement from federal agencies against medspa prescribers aligns with the administration’s heightened commitment to prosecuting the distribution of unapproved products.
Earnouts and other forms of deferred consideration can be useful tools in physician practice transactions so long as risks for post-closing disputes and regulatory exposure are addressed.
A significant and distinct permission under New Jersey’s guardianship statute for initiating an application for adult guardianship becomes effective on April 1, 2026.
CMS’ latest memo announced that additional flexibilities affecting CLIA-certified laboratories will end as of March 23, 2026.
Effective Jan. 1, 2028, no payment under the Medicare Outpatient Prospective Payment System will be made for items or services furnished by an off-campus provider-based department of a hospital unless certain billing requirements are met.
Employment agreements with hospitals, clinics or large health systems frequently include restrictive covenants that could inhibit a provider in pursuing his or her professional ambitions.
By the Feb. 16, 2026 compliance deadline, entities subject to the Part 2 regulations must update their policies, procedures and forms to comply with Final Rule regulatory changes.
Understanding New Jersey’s Corporate Practice of Medicine can aid health care professionals in successfully owning and operating a medical spa or similar type of provider.
We examine key updates to laboratory supervision and oversight standards, among other changes, and their impact on Pennsylvania clinical laboratories.
State regulators are using consumer protection law, unfair trade practice statutes and public health authority to intervene in GLP-1 distribution channels that operate outside the bounds of federal drug law.
Part 2 is applicable to records related to the identity, diagnosis, prognosis or treatment of any individual in a federally assisted substance use disorder program.
Health care providers must examine their digital ecosystems carefully to ensure compliance, mitigate data risks and maintain public trust.
In a medical practice, building an effective compliance program means nurturing a culture of accountability and trust among all staff.
The ongoing Shutdown is anticipated to significantly delay actions that require CMS certification and should therefore be taken into consideration when planning for any current or future projects.
Federal agencies have M&A in their sights as they continue to emphasize accountability, individual liability and program integrity in health care.
By remaining compliant with key telehealth delivery standards, telehealth providers can avoid or mitigate exposure from changes in reimbursement requirements from Medicare.
We break down health care sector highlights and FTC merger enforcement actions reported in the 2024 fiscal year.
The FTC made clear its continued commitment to enforcing Section 8 of the Clayton Act, which prohibits directors and officers from serving simultaneously on the boards of competitors.